Work

Valganciclovir prevents cytomegalovirus reactivation in patients receiving alemtuzumab-based therapy

Year: 2007

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Blood

DOI: 10.1182/blood-2007-03-080010

Authors: Susan O'Brien, Farhad Ravandi, Todd Riehl, William Wierda, Xuelin Huang, Jeffrey Tarrand, Brandi O'Neal, Hagop Kantarjian, Michael Keating

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Cytomegalovirus and herpesvirus research

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2019779933

FWCI: 7.325

Cites: 14

Cited by: 88

Related to: 10